Subependymal giant cell astrocytoma (SEGA), another TSC associated neoplasm, can also be successfully managed by mTOR inhibition, and everolimus is already an FDA-approved drug for non-resectable SEGAs[9]. The gene discussed is MTOR; the disease is subependymal giant cell astrocytoma.